Strength
2.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862082590
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
SAXAGLIPTIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205972On Market Since
7/31/2023
Pharmacological Classes
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors
Related Drugs
Same classification
SAXAGLIPTIN HCL 5 MG TABLET
Generic
00378470677•Mylan Pharmaceuticals Inc.
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
00378470693•Mylan Pharmaceuticals Inc.
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
68462072730•Glenmark Pharmaceuticals Inc., USA
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
68462072790•Glenmark Pharmaceuticals Inc., USA
$1.1692
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
00378470577•Mylan Pharmaceuticals Inc.
$1.2833
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
00378470593•Mylan Pharmaceuticals Inc.
$1.2833
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
68462072630•Glenmark Pharmaceuticals Inc., USA
$1.2833
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
68462072690•Glenmark Pharmaceuticals Inc., USA
$1.2833
per EA
ALOGLIPTIN-METFORMIN 12.5-500
Generic
45802016972•Padagis Israel Pharmaceuticals Ltd
$2.1623
per EA
ALOGLIPTIN-METFORMIN 12.5-1000
Generic
45802021172•Padagis Israel Pharmaceuticals Ltd
$2.5444
per EA